Term
|
Definition
Muscarinic, Nicotinic Agonist
Susceptible to ACHE breakdown |
|
|
Term
|
Definition
| Muscarinic Agonist (Also AchE-I effect) |
|
|
Term
|
Definition
| Muscarinic, Nicotinic Agonist (Also ACHE-I effect) |
|
|
Term
|
Definition
Muscarinic Agonist (Respiratory Diagnostic)
Quat.
Susceptible to ACHE breakdown |
|
|
Term
|
Definition
| Muscarinic, Nicotinic Agonist |
|
|
Term
|
Definition
Muscarinic Agonist
Tert. Can be taken orally for systemic effect. |
|
|
Term
|
Definition
Muscarinic Agonist
Tert. Can be taken orally for systemic effect. |
|
|
Term
|
Definition
Muscarinic Agonist
Clinical Trial for alzheimer's |
|
|
Term
|
Definition
Muscarinic Agonist
Tert. Can be taken orally for systemic effect. For Sjogren's
CYP metabolized/interactions. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Partial Nicotinic Agonist
For smoking cessations |
|
|
Term
|
Definition
Reversible ACHE Inhibitor
Quat. For Myasthenia Gravis |
|
|
Term
|
Definition
Reversible ACHE Inhibitor
Crosses BBB
CYP metabolized/interactions. |
|
|
Term
|
Definition
Reversible ACHE Inhibitor
Quat. Diagnostic for Myasthenia Gravis |
|
|
Term
|
Definition
Reversible ACHE Inhibitor
Crosses BBB.
CYP metabolized/interactions. |
|
|
Term
|
Definition
Reversible ACHE Inhibitor
Crosses BBB.
CYP hepatotoxicity/interactions. |
|
|
Term
|
Definition
Semi-reversible ACHE Inhibitor
Quat. "Bis-Neostigmine" |
|
|
Term
|
Definition
Semi-reversible ACHE Inhibitor
Tert. Can cross BBB. For treating CNS toxicity of anti-Achs. |
|
|
Term
|
Definition
Semi-reversible ACHE Inhibitor
Quat. |
|
|
Term
|
Definition
Semi-reversible ACHE Inhibitor (Also direct Ach Agonist)
Quat. |
|
|
Term
|
Definition
Semi-reversible ACHE Inhibitor
Tert. Can cross BBB. For Alzheimer's |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor (Nerve Gas) |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor (Nerve Gas) |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor (Nerve Gas) |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor (Pesticide) |
|
|
Term
|
Definition
| Irreversible ACHE Inhibitor (Pesticide |
|
|
Term
|
Definition
Irreversible ACHE Inhibitor (Therapeutic)
Quat. For Glaucoma. Cannot be absorbed systemically through skin. |
|
|
Term
|
Definition
Irreversible ACHE Inhibitor (Therapeutic)
Can be absorbed systemically through skin.
For Glaucoma. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Muscarinic Blocker
Tert. For inducing mydriasis and produces cycloplegia during eye exams. |
|
|
Term
|
Definition
Muscarinic Blocker
Quat. For bronchospasm/COPD |
|
|
Term
|
Definition
|
|
Term
|
Definition
Muscarinic Blocker
Quat. For bronchospasm/COPD |
|
|
Term
|
Definition
M-1 Blocker
For Peptic Ulcers |
|
|
Term
|
Definition
M-1 Blocker
For Peptic Ulcers |
|
|
Term
|
Definition
M-2 Blocker
For CVS failure |
|
|
Term
|
Definition
M-3 (The most selective)
Tert. For overactive bladder.
CYP metabolism/interactions |
|
|
Term
|
Definition
M-3 Blocker
Tert. For overactive bladder.
CYP metabolism/interactions |
|
|
Term
|
Definition
Muscarinic Blocker
For Parkinson's |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Muscarinic Blocker
Quat. For peptic Ulcers, Hyperhidrosis, |
|
|
Term
|
Definition
Muscarinic Blocker
Tert. For overactive bladder
CYP metabolism/interactions |
|
|
Term
|
Definition
Muscarinic Blocker
For Parkinson's |
|
|
Term
|
Definition
Muscarinic Blocker
Tert. For inducing mydriasis and produces cycloplegia during eye exams. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Muscarinic Block Side effect |
|
|
Term
|
Definition
| Muscarinic Block Side effect |
|
|
Term
|
Definition
| Muscarinic Block Side effect |
|
|
Term
|
Definition
| Muscarinic Block Side effect |
|
|
Term
|
Definition
| Ganglionic Nicotinic Blocker. |
|
|
Term
|
Definition
Ganglionic Nicotinic Blocker.
Crosses BBB. For Smoking Cessation |
|
|
Term
|
Definition
| Ganglionic Nicotinic Blocker. |
|
|
Term
|
Definition
| Ganglionic Nicotinic Blocker. |
|
|
Term
|
Definition
NMJ Nicotinic Blocker.
Quat. |
|
|
Term
|
Definition
|
|
Term
|
Definition
NMJ Nicotinic Blocker. (Natural)
Long-Acting |
|
|
Term
|
Definition
| Depolarizing Nicotinic Blocker. |
|
|
Term
|
Definition
Depolarizing Nicotinic Blocker.
Ultra-short acting |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Potency: Dox>Miv>Atra
Duration: Dox>Atra>Miva |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Potency: Dox>Miv>Atra
Duration: Dox>Atra>Miva |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Potency: Dox>Miv>Atra
Duration: Dox>Atra>Miva |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Quat/Quat = Greater potency/duration
Elimination is more renal |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Quat/Quat = Greater potency/duration
Elimination is more renal |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Tert/Quat - Less Potency
Shortest duration |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Tert/Quat - Less Potency
Duration: Pan/Pip>Roc/Vec>Rap |
|
|
Term
|
Definition
Competitive Nicotinic Blocker.
Tert/Quat - Less potency, but more than Rap/Roc |
|
|
Term
| 2-PAM (Pyridine-2-Aldoxime Methiodide) |
|
Definition
| Antidote to Organophosphate Poisoning |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Alpha-latrotoxin (Spider venom) |
|
Definition
| Vesicular releaser of Ach |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
